Biogen'a Q1 profit and revenue lag estimates, weighed down by Alzheimer's drugMarket Watch • 05/03/22
Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD)Business Wire • 05/02/22
Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/26/22
Biogen stock slides 2% after it withdraws authorization application with EU regulatorMarket Watch • 04/22/22